EICHORCondition: Alzheimer's Disease · Dementia · Brain Diseases · Sponsor: Eli Lilly and Company
This study will investigate different donanemab dosing regimens and their effect on the frequency and severity of ARIA-E in adults with early symptomatic Alzheimer's disease (AD) and explore participant characteristics that might predict risk of ARIA. Approximately 375 additional participants will be enrolled in addendum 2. Addendum 3 includes a subset of participants from the main study to receive a single dose. The study will last approximately 91 weeks and include up to 26 visits in the main study.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| MD First Research - Chandler | Chandler, Arizona, United States | — |
| Irvine Clinical Research | Irvine, California, United States | — |
| Healthy Brain Clinic | Long Beach, California, United States | — |
| California Neuroscience Research Medical Group, Inc. | Sherman Oaks, California, United States | — |
| JEM Research Institute | Atlantis, Florida, United States | — |
| VIN-Julie Schwartzbard | Aventura, Florida, United States | — |
| Excel Medical Clinical Trials | Boca Raton, Florida, United States | — |
| K2 Medical Research | Clermont, Florida, United States | — |
| Brain Matters Research | Delray Beach, Florida, United States | — |
| Neuropsychiatric Research Center of Southwest Florida | Fort Myers, Florida, United States | — |
| Finlay Medical Research | Greenacres City, Florida, United States | — |
| Infinity Clinical Research, LLC | Hollywood, Florida, United States | — |
+ 37 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05738486